SEC Insider Transactions from Ye Weiguo.

Last updated: 2026-05-20 21:11 UTC | Total transactions: 21

Ye Weiguo has filed 21 insider transactions across 1 company since March 2025.

Most recent transaction: a option exercise of 200 shares of GYRE THERAPEUTICS, INC. ($GYRE) on May 18, 2026.

Activity breakdown: 0 open-market purchases and 4 sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
May 18, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 200 $0.75 700,200.0000 103,971,546 0.03% 0.00%
May 19, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 9120 $0.00 927,115.0000 103,971,546 0.97% 0.01%
May 18, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 200 $0.00 936,235.0000 103,971,546 0.02% 0.00%
May 19, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer S Common Stock 9120 $6.37 700,000.0000 103,971,546 1.29% 0.01%
May 19, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 9120 $0.75 709,120.0000 103,971,546 1.30% 0.01%
May 18, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer S Common Stock 200 $6.62 700,000.0000 103,971,546 0.03% 0.00%
May 14, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer S Common Stock 15580 $6.91 700,000.0000 103,971,546 2.18% 0.01%
May 14, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 15580 $0.75 715,580.0000 103,971,546 2.23% 0.01%
May 15, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 13100 $0.75 713,100.0000 103,971,546 1.87% 0.01%
May 15, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer S Common Stock 13100 $6.65 700,000.0000 103,971,546 1.84% 0.01%
May 14, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 15580 $0.00 949,535.0000 103,971,546 1.61% 0.01%
May 15, 2026 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 13100 $0.00 936,435.0000 103,971,546 1.38% 0.01%
April 1, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 50000 $0.75 700,000.0000 102,293,526 7.69% 0.05%
April 1, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 50000 $0.00 965,115.0000 102,293,526 4.93% 0.05%
March 26, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 200000 $0.00 1,165,115.0000 102,293,526 14.65% 0.20%
March 27, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 150000 $0.00 1,015,115.0000 102,293,526 12.87% 0.15%
March 24, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Stock Option (Right to Buy) 300000 $0.00 1,365,115.0000 102,293,526 18.02% 0.29%
March 27, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 150000 $0.75 650,000.0000 102,293,526 30.00% 0.15%
March 24, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 300000 $0.75 300,000.0000 102,293,526 9999.99% 0.29%
March 26, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer M Common Stock 200000 $0.75 500,000.0000 102,293,526 66.67% 0.20%
March 7, 2025 GYRE THERAPEUTICS, INC. $GYRE Ye Weiguo Chief Operating Officer A Stock Option (Right to Buy) 300000 $0.00 300,000.0000 102,293,526 9999.99% 0.29%